Vivo Bio Tech (BOM:511509) Total Operating Expense: ₹371.3 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:511509 Vivo Bio Tech Ltd BOM:511509
64 GF Score
Price ₹23.41
GF Value ₹30.49
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Vivo Bio Tech Total Operating Expense?

Vivo Bio Tech BOM:511509 -7.07% 64 Total Operating Expense is ₹371.3 Mil as of Jun. 2026. GuruFocus rates BOM:511509 with a GF Score™ of 64/100 and a GF Value™ of ₹30.49 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Vivo Bio Tech's Total Operating Expense for the three months ended in Jun. 2026 was ₹109.0 Mil. Vivo Bio Tech's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹371.3 Mil.

Vivo Bio Tech Total Operating Expense Related Terms

Vivo Bio Tech Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Vivo Bio Tech's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech Total Operating Expense Chart

Vivo Bio Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 312.11 328.90 296.11 293.89 343.85

Vivo Bio Tech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.60 81.71 85.22 95.32 109.03
BOM:511509
64GF Score
Vivo Bio Tech Ltd BOM:511509
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivo Bio Tech Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹371.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹371.3 Mil mean?
Vivo Bio Tech (BOM:511509) has a Total Operating Expense of ₹371.3 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Vivo Bio Tech and its competitors.
Is Vivo Bio Tech's Total Operating Expense too high?
Vivo Bio Tech's current Total Operating Expense is ₹371.3 Mil. Overall, Vivo Bio Tech has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Total Operating Expense compare to VRTX and REGN?
Vivo Bio Tech's Total Operating Expense of ₹371.3 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Vivo Bio Tech and its competitors. Vivo Bio Tech's current Total Operating Expense is ₹371.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹30.49, compared to a current price of ₹23.41 — trading 23.2% below its estimated fair value. The current Total Operating Expense is ₹371.3 Mil. Vivo Bio Tech's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Total Operating Expense is ₹371.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?

Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued. The current stock price of ₹23.41 is trading 23.2% below its estimated GF Value™ of ₹30.49. GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.

Key valuation signals for BOM:511509:

  • Total Operating Expense: ₹371.3 Mil
  • GF Value™: ₹30.49 vs. price of ₹23.41 (23.2% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivo Bio Tech Business Description

Address Number 8-2-672/ 5 & 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
64GF Score

Get the complete analysis for BOM:511509

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.41
Price
₹30.49
GF Value